|
Synonyms: AC01 | HM-01 | HM01
Compound class:
Synthetic organic
Comment: Drocamorelin (AC01, formerly HM01) is reported as a brain‐penetrating, orally bioavailable, ghrelin peptidomimetic small-molecule agonist [1]. In preclinical models HM01 stimulates gastrointestinal motility, with effects on gastric inflammation and emptying, that are mediated via central and enteric neurons [2-4]. In the heart drocamorelin acts as a calcium sensitizing inotrope that increases cardiac contractility and force, and for this action it has been proposed for the treatment of chronic heart failure.
The chemical structure of AC01/HM01 was matched to that for the INN drocamorelin, as revealed in WHO INN Proposed List 135 (July 2026). Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Karasawa H, Pietra C, Giuliano C, Garcia-Rubio S, Xu X, Yakabi S, Taché Y, Wang L. (2014)
New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease. Neurogastroenterol Motil, 26 (12): 1771-82. [PMID:25327342] |
|
2. Naitou K, Mamerto T, Pustovit RV, Rivera LR, Callaghan B, Ringuet MT, Chan A, Pietra C, Furness JB. (2015)
The ghrelin receptor agonist, HM01, activates the innervation of the colon to initiate coordinated propulsive contractions and bowel emptying. Autonomic Neuroscience: Basic & Clinical, 192: p58-59. DOI: 10.1016/j.autneu.2015.07.018 |
|
3. Tu L, Lu Z, Ngan MP, Lam FFY, Giuliano C, Lovati E, Pietra C, Rudd JA. (2020)
The brain-penetrating, orally bioavailable, ghrelin receptor agonist HM01 ameliorates motion-induced emesis in Suncus murinus (house musk shrew). Br J Pharmacol, 177 (7): 1635-1650. [PMID:31722444] |
|
4. Yuan PQ, Wu SV, Wang L, Taché Y. (2023)
The ghrelin agonist, HM01 activates central vagal and enteric cholinergic neurons and reverses gastric inflammatory and ileus responses in rats. Neurogastroenterol Motil, 35 (5): e14561. [PMID:36942655] |